PubRank

Lynn M Matrisian

Author PubWeight™ 130.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002 12.29
2 Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004 7.61
3 The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 2009 6.83
4 Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 2008 6.78
5 Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002 5.73
6 Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007 3.81
7 Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 2004 2.96
8 MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell 2005 2.65
9 Matrix metalloproteinase-7 is expressed by pancreatic cancer precursors and regulates acinar-to-ductal metaplasia in exocrine pancreas. J Clin Invest 2002 2.28
10 Matrix metalloproteinases in tumor-host cell communication. Differentiation 2002 2.16
11 The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007 2.07
12 Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 2006 1.97
13 Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res 2008 1.88
14 Pancreatic cancer clinical trials and accrual in the United States. J Clin Oncol 2013 1.81
15 Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 2006 1.75
16 Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents. Cancer Res 2010 1.66
17 Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 2004 1.65
18 TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res 2010 1.57
19 Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 2008 1.54
20 Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol 2004 1.52
21 Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res 2006 1.50
22 Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation 2006 1.46
23 Matrix metalloproteases in head and neck cancer. Head Neck 2006 1.35
24 Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 2002 1.35
25 Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology 2003 1.34
26 Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler Thromb Vasc Biol 2006 1.34
27 A protective role for matrix metalloproteinase-3 in squamous cell carcinoma. Cancer Res 2004 1.32
28 Matrix metalloproteinases in colorectal cancer: is it worth talking about? Cancer Metastasis Rev 2004 1.26
29 Analysis of host- and tumor-derived proteinases using a custom dual species microarray reveals a protective role for stromal matrix metalloproteinase-12 in non-small cell lung cancer. Cancer Res 2006 1.26
30 Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol Imaging 2009 1.25
31 Molecular imaging of proteolytic activity in cancer. J Cell Biochem 2003 1.19
32 Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Mol Imaging 2007 1.18
33 The Translational Research Working Group developmental pathways: introduction and overview. Clin Cancer Res 2008 1.18
34 Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006 1.16
35 Increased plasma MMP9 in integrin alpha1-null mice enhances lung metastasis of colon carcinoma cells. Int J Cancer 2005 1.14
36 Warm hepatic ischemia-reperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Res 2007 1.11
37 Matrix metalloproteinase 7 mediates mammary epithelial cell tumorigenesis through the ErbB4 receptor. Cancer Res 2007 1.10
38 Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions. Mol Cancer Res 2012 1.10
39 The Translational Research Working Group developmental pathway for image-based assessment modalities. Clin Cancer Res 2008 1.09
40 Matrilysin-dependent elastolysis by human macrophages. J Exp Med 2003 1.08
41 Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One 2011 1.08
42 Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS One 2011 1.08
43 A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 2008 1.04
44 The serum glycoprotein fetuin-A promotes Lewis lung carcinoma tumorigenesis via adhesive-dependent and adhesive-independent mechanisms. Cancer Res 2005 1.03
45 Matrix metalloproteinase-9 contributes to intestinal tumourigenesis in the adenomatous polyposis coli multiple intestinal neoplasia mouse. Int J Exp Pathol 2008 1.02
46 Resident stromal cell-derived MMP-9 promotes the growth of colorectal metastases in the liver microenvironment. Int J Cancer 2007 0.99
47 Matrix metalloproteinases and cellular motility in development and disease. Birth Defects Res C Embryo Today 2006 0.99
48 Osteoclast-derived matrix metalloproteinase-7, but not matrix metalloproteinase-9, contributes to tumor-induced osteolysis. Cancer Res 2009 0.98
49 A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo. Hybridoma (Larchmt) 2007 0.97
50 Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: implications in cellular invasion. FASEB J 2003 0.97
51 Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters. Mol Carcinog 2004 0.96
52 An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment. PLoS One 2012 0.95
53 Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer. Cancer Res 2008 0.94
54 The influence of matrix metalloproteinase-7 on early mammary tumorigenesis in the multiple intestinal neoplasia mouse. Oncol Rep 2004 0.93
55 Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice. Invest Ophthalmol Vis Sci 2003 0.93
56 Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A. Biochim Biophys Acta 2004 0.92
57 The application of a murine bone bioreactor as a model of tumor: bone interaction. Clin Exp Metastasis 2006 0.92
58 Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo. Cancer Res 2002 0.91
59 Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment. Mol Cancer Res 2007 0.91
60 Keratinocyte expression of MMP3 enhances differentiation and prevents tumor establishment. Am J Pathol 2008 0.91
61 An orthotopic model of lung cancer to analyze primary and metastatic NSCLC growth in integrin alpha1-null mice. Clin Exp Metastasis 2005 0.91
62 Optical proteolytic beacons for in vivo detection of matrix metalloproteinase activity. Methods Mol Biol 2009 0.89
63 Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA. J Oncol 2010 0.89
64 Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis. Mol Carcinog 2002 0.88
65 Establishment and quantitative imaging of a 3D lung organotypic model of mammary tumor outgrowth. Clin Exp Metastasis 2008 0.88
66 Rapid extravasation and establishment of breast cancer micrometastases in the liver microenvironment. Mol Cancer Res 2010 0.88
67 Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI. Magn Reson Med 2008 0.86
68 Epidermal growth factor upregulates matrix metalloproteinase-7 expression through activation of PEA3 transcription factors. Int J Oncol 2004 0.86
69 Near-infrared optical proteolytic beacons for in vivo imaging of matrix metalloproteinase activity. Methods Mol Biol 2010 0.85
70 Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model. Cancer Res 2007 0.84
71 It's not my fault, blame it on my microenvironment. Differentiation 2002 0.83
72 Salivary proteinase activity: a potential biomarker for preterm premature rupture of the membranes. Am J Obstet Gynecol 2006 0.83
73 Proteinase activity in human and murine saliva as a biomarker for proteinase inhibitor efficacy. Clin Cancer Res 2004 0.82
74 The Translational Research Working Group developmental pathway for anticancer agents (drugs or biologics). Clin Cancer Res 2008 0.81
75 Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activity in polarized MDCK cells. Exp Cell Res 2004 0.80
76 Interactions of alpha2-HS-glycoprotein (fetuin) with MMP-3 and murine squamous cell carcinoma cells. Int J Oncol 2002 0.80
77 Synthesis and in vitro efficacy of MMP9-activated NanoDendrons. Mol Pharm 2013 0.79
78 MMP-2 contributes to the development of the mouse ventral prostate by impacting epithelial growth and morphogenesis. Dev Dyn 2010 0.79
79 Alpha 2-HS glycoprotein (fetuin-A) modulates murine skin tumorigenesis. Int J Oncol 2004 0.77
80 The Translational Research Working Group developmental pathway for interventive devices. Clin Cancer Res 2008 0.76
81 Increased metastases are associated with inflammation and matrix metalloproteinase-9 activity at incision sites in a murine model of peritoneal dissemination of colorectal cancer. J Surg Res 2012 0.76
82 In the forefront of basic and translational cancer research: Seventh Joint Conference of the American Association for Cancer Research and the Japanese Cancer Association. Cancer Res 2007 0.76